Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Optical Cytosensors for the Detection of Circulating Tumour Cells Publisher Pubmed



Vajhadin F1 ; Mazloumardakani M1 ; Sanati A2 ; Haghniaz R3 ; Travassejdic J4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Chemistry, Yazd University, Faculty of Science, Yazd, 8915818411, Iran
  2. 2. Biosensor Research Center, Isfahan University of Medical Sciences, School of Advanced Technologies in Medicine, Isfahan, Iran
  3. 3. Terasaki Institute for Biomedical Innovation, Los Angeles, 90064, CA, United States
  4. 4. Polymer Biointerface Centre, The University of Auckland, School of Chemical Sciences, Auckland, 1010, New Zealand
  5. 5. MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington, 6140, New Zealand

Source: Journal of Materials Chemistry B Published:2022


Abstract

Blood analysis is an established approach to monitor various diseases, ranging from heart defects and diabetes to cancer. Among various tumor markers in the blood, circulating tumor cells (CTCs) have received increasing attention due to the fact that they originate directly from the tumors. Capturing and detecting CTCs represents a promising approach in cancer diagnostics and clinical management of cancers. CTCs in blood progress to self-seeding a tumour or initiating a new lesion mass. Cytosensors are biosensors intended to identify CTCs in a blood sample of cancer patients and provide information about the cancer status. Herein, we firstly discuss different detection methods of state-of-the-art optical cytosensors, including colorimetry, fluorescence, surface plasmon resonance, photoelectrochemistry and electrochemiluminescence. Then we review the significant advances made in implementing biorecognition elements and nanomaterials for the detection of cancer cells. Despite great progress in optical cytosensors, and their integration with smartphones, they have still only been explored to prototype stages. Much more effort is needed to fulfil their potential in modern cancer diagnostics and in monitoring the state of disease for cancer patients. This journal is © The Royal Society of Chemistry